ROCHE HOLDING LTD (RHHVF)
Clinical trial NCT03107871 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2024-07-01 → 2022-08-31 3. primary completion date: 2022-07-01 → 2022-08-31 4. enrollment: 52 → 10 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical